Figures & data
Figure 1 Schematic diagram of methodology.
Abbreviations: FDA, US Food and Drug Administration; PGx, pharmacogenetic.
Table 1 Summary of patient-related sections of drug labels listed in the FDA table of Pharmacogenomic Biomarkers in Drug Labels
Table 2 Summary of content analysis of 29 drug labels with PGx information in patient-targeted sections
Table S1 Patient-targeted sections of drug labels used for content analysis (due to copyright restrictions, we are not able to provide the full text used in the content analysis but refer the reader to the noted section in the drug label at the provided URL accessible through the US Food and Drug Administration)